Cargando…
Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients
BACKGROUND/AIM: Right sided colon cancer (RsCC) is proposed to be a distinct disease entity to left sided colon cancer (LsCC). We seek to confirm primary tumour location as an independent prognostic factor in locoregional colorectal cancer. METHODS: All patients with stage I – III primary adenocarci...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385038/ https://www.ncbi.nlm.nih.gov/pubmed/28390415 http://dx.doi.org/10.1186/s12885-017-3255-z |
_version_ | 1782520531532120064 |
---|---|
author | Brungs, Daniel Aghmesheh, Morteza de Souza, Paul Ng, Weng Chua, Wei Carolan, Martin Clingan, Philip Healey, Emma Rose, June Tubaro, Tameika Ranson, Marie |
author_facet | Brungs, Daniel Aghmesheh, Morteza de Souza, Paul Ng, Weng Chua, Wei Carolan, Martin Clingan, Philip Healey, Emma Rose, June Tubaro, Tameika Ranson, Marie |
author_sort | Brungs, Daniel |
collection | PubMed |
description | BACKGROUND/AIM: Right sided colon cancer (RsCC) is proposed to be a distinct disease entity to left sided colon cancer (LsCC). We seek to confirm primary tumour location as an independent prognostic factor in locoregional colorectal cancer. METHODS: All patients with stage I – III primary adenocarcinoma of colon were identified from the New South Wales (NSW) clinical cancer registry (2006–2013). Primary tumour location (RsCC vs LsCC) survival analyses were conducted using the Kaplan-Meier method, and adjusted hazard ratios for 5-year all-cause mortality (OS) and 5-year cancer specific mortality (CSS) were obtained using Cox proportional hazards regression. RESULTS: We identified 9509 patients including 5051 patients with RsCC and 4458 with LsCC. Patients with RsCC were more likely to be older, female, have a higher Charlson comorbidity index, and have worse tumour prognostic factors. In univariate analysis of all stages combined, those patients with RsCC had a worse overall survival (OS, HR 1.20 95% CI 1.11–1.29, p < 0.0001), although this was not significant in the multivariate analysis (HR 0.96 95% CI 0.89–1.04, p = 0.35). Stage I patients with RsCC had a trend to improved OS (multivariate HR 0.84 95% CI 0.69–1.01, p = 0.07) and a significantly improved CSS (multivariate HR 0.51 95% CI 0.35–0.75, p = 0.0006). In stage II patients with RsCC there was a significantly improved OS (multivariate HR 0.85 95% CI 0.75–0.98, p = 0.02) and CSS (multivariate HR 0.59 95% CI 0.45–0.78, p = 0.0002) compared to LsCC. In stage III patients, those with RsCC had a worse OS (multivariate HR 1.13 95% CI 1.01–1.26, p = 0.032) and a trend to worse CSS (multivariate HR 1.12 95% CI 0.94–1.33, p = 0.22). CONCLUSIONS: Primary tumour location is an important prognostic factor in locoregional colon cancer with an effect that varies by stage. RsCC is associated with lower all-cause mortality in stage II, and higher all-cause mortality in stage III. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3255-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5385038 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53850382017-04-12 Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients Brungs, Daniel Aghmesheh, Morteza de Souza, Paul Ng, Weng Chua, Wei Carolan, Martin Clingan, Philip Healey, Emma Rose, June Tubaro, Tameika Ranson, Marie BMC Cancer Research Article BACKGROUND/AIM: Right sided colon cancer (RsCC) is proposed to be a distinct disease entity to left sided colon cancer (LsCC). We seek to confirm primary tumour location as an independent prognostic factor in locoregional colorectal cancer. METHODS: All patients with stage I – III primary adenocarcinoma of colon were identified from the New South Wales (NSW) clinical cancer registry (2006–2013). Primary tumour location (RsCC vs LsCC) survival analyses were conducted using the Kaplan-Meier method, and adjusted hazard ratios for 5-year all-cause mortality (OS) and 5-year cancer specific mortality (CSS) were obtained using Cox proportional hazards regression. RESULTS: We identified 9509 patients including 5051 patients with RsCC and 4458 with LsCC. Patients with RsCC were more likely to be older, female, have a higher Charlson comorbidity index, and have worse tumour prognostic factors. In univariate analysis of all stages combined, those patients with RsCC had a worse overall survival (OS, HR 1.20 95% CI 1.11–1.29, p < 0.0001), although this was not significant in the multivariate analysis (HR 0.96 95% CI 0.89–1.04, p = 0.35). Stage I patients with RsCC had a trend to improved OS (multivariate HR 0.84 95% CI 0.69–1.01, p = 0.07) and a significantly improved CSS (multivariate HR 0.51 95% CI 0.35–0.75, p = 0.0006). In stage II patients with RsCC there was a significantly improved OS (multivariate HR 0.85 95% CI 0.75–0.98, p = 0.02) and CSS (multivariate HR 0.59 95% CI 0.45–0.78, p = 0.0002) compared to LsCC. In stage III patients, those with RsCC had a worse OS (multivariate HR 1.13 95% CI 1.01–1.26, p = 0.032) and a trend to worse CSS (multivariate HR 1.12 95% CI 0.94–1.33, p = 0.22). CONCLUSIONS: Primary tumour location is an important prognostic factor in locoregional colon cancer with an effect that varies by stage. RsCC is associated with lower all-cause mortality in stage II, and higher all-cause mortality in stage III. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3255-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-08 /pmc/articles/PMC5385038/ /pubmed/28390415 http://dx.doi.org/10.1186/s12885-017-3255-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Brungs, Daniel Aghmesheh, Morteza de Souza, Paul Ng, Weng Chua, Wei Carolan, Martin Clingan, Philip Healey, Emma Rose, June Tubaro, Tameika Ranson, Marie Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients |
title | Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients |
title_full | Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients |
title_fullStr | Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients |
title_full_unstemmed | Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients |
title_short | Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients |
title_sort | sidedness is prognostic in locoregional colon cancer: an analysis of 9509 australian patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385038/ https://www.ncbi.nlm.nih.gov/pubmed/28390415 http://dx.doi.org/10.1186/s12885-017-3255-z |
work_keys_str_mv | AT brungsdaniel sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients AT aghmeshehmorteza sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients AT desouzapaul sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients AT ngweng sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients AT chuawei sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients AT carolanmartin sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients AT clinganphilip sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients AT healeyemma sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients AT rosejune sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients AT tubarotameika sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients AT ransonmarie sidednessisprognosticinlocoregionalcoloncancerananalysisof9509australianpatients |